Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001048291 | SCV001212286 | pathogenic | Neurofibromatosis, type 1 | 2024-10-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Phe1458Serfs*4) in the NF1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NF1 are known to be pathogenic (PMID: 10712197, 23913538). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with NF1-related conditions. ClinVar contains an entry for this variant (Variation ID: 845258). For these reasons, this variant has been classified as Pathogenic. |
Centre for Mendelian Genomics, |
RCV001048291 | SCV001368200 | pathogenic | Neurofibromatosis, type 1 | 2019-06-21 | criteria provided, single submitter | clinical testing | This variant was classified as: Pathogenic. The following ACMG criteria were applied in classifying this variant: PVS1,PM2,PP4. |
Genome- |
RCV001048291 | SCV002560056 | pathogenic | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing |